Lee Suhwan, Kim Hyun-Ah, Yoon Young Hee
Department of Ophthalmology, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Republic of Korea.
Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ophthalmol Retina. 2019 Aug;3(8):681-689. doi: 10.1016/j.oret.2019.03.014. Epub 2019 Apr 4.
We aimed to describe the vascular changes in eyes associated with tamoxifen retinopathy using OCT angiography (OCTA) and to compare these changes with abnormalities in macular telangiectasia type 2 (MacTel 2) previously reported in the literature.
Retrospective, observational study.
Seventeen eyes with tamoxifen retinopathy and 17 eyes of age-matched healthy control participants.
The medical records of patients who visited the ophthalmology department with a history of taking tamoxifen were reviewed. Tamoxifen retinopathy was diagnosed based on typical spectral-domain (SD) OCT findings, such as intraretinal cavitation, photoreceptor disruption, or both. Multimodal imaging, particularly focused on OCTA, was analyzed. To compare vessel density in OCTA, age-matched normal control participants also were enrolled.
Descriptive appraisal of the vascular abnormalities and objective quantification of vessel density associated with tamoxifen retinopathy.
Among 292 patients who were screened, 26 were diagnosed with tamoxifen retinopathy. Of these, 17 eyes of 10 patients who were evaluated using OCTA were included. All patients were women, with a median patient age of 65.0 years. They were treated with tamoxifen as adjuvant endocrine therapy for breast cancer. All eyes showed intraretinal cavitation, and 8 eyes showed focal photoreceptor disruption as well, on OCT. On OCTA imaging, 14 eyes (82.4%) showed saccular capillary telangiectasia at the deep capillary plexus and 6 eyes (35.3%) showed right-angled vessels. Foveal vessel density of the superficial plexus was significantly lower in eyes with tamoxifen retinopathy than in control participants (P = 0.003). Crystalline deposits on fundus photographs (12 eyes [70.6%]) and increased autofluorescence on fundus autofluorescence (16 eyes [94.1%]) also were noted as characteristic findings of tamoxifen retinopathy.
In addition to morphologic changes of tamoxifen retinopathy in SD OCT, its vascular changes on OCTA, such as telangiectatic vascular change at the deep capillary plexus and right-angled vessels, are similar to those observed in the early stages of MacTel 2.
我们旨在利用光学相干断层扫描血管造影(OCTA)描述与他莫昔芬视网膜病变相关的眼部血管变化,并将这些变化与文献中先前报道的2型黄斑毛细血管扩张症(MacTel 2)的异常情况进行比较。
回顾性观察研究。
17例患有他莫昔芬视网膜病变的患者的眼睛以及17例年龄匹配的健康对照参与者的眼睛。
回顾了有服用他莫昔芬病史且到眼科就诊的患者的病历。基于典型的光谱域(SD)OCT表现,如视网膜内空洞形成、光感受器破坏或两者兼有,诊断他莫昔芬视网膜病变。分析了多模态成像,尤其着重于OCTA。为比较OCTA中的血管密度,还纳入了年龄匹配的正常对照参与者。
对与他莫昔芬视网膜病变相关的血管异常进行描述性评估,并对血管密度进行客观量化。
在筛查的292例患者中,26例被诊断为他莫昔芬视网膜病变。其中,10例接受OCTA评估的患者的17只眼睛被纳入研究。所有患者均为女性,患者年龄中位数为65.0岁。她们接受他莫昔芬作为乳腺癌的辅助内分泌治疗。在OCT上,所有眼睛均显示视网膜内空洞形成,8只眼睛还显示有局灶性光感受器破坏。在OCTA成像上,14只眼睛(82.4%)在深层毛细血管丛处显示囊状毛细血管扩张,6只眼睛(35.3%)显示直角血管。他莫昔芬视网膜病变患者眼睛的浅表丛中心凹血管密度显著低于对照参与者(P = 0.003)。眼底照片上的结晶沉积物(12只眼睛[7